Jason Farley, PhD, MPH, CRNP, FAAN

Faculty

Titles:

Associate Professor, School of Nursing

SciVal:

SciVal Link

Dr. Jason Farley, Director of the Johns Hopkins National AIDS Education and Training Center, is an Associate Professor of Nursing and an Adult Nurse Practitioner in the Division of Infectious Diseases and President-Elect of the Association of Nurses in AIDS Care (ANAC).  I have 16 years of nursing experience with 11 years of clinical experience as an HIV/AIDS adult primary care nurse practitioner in the Moore Clinic of the Johns Hopkins AIDS Service. I am a Fellow in the American Academy of Nursing and hold an adjunct Associate Professor appointment at the University of KwaZulu Natal in the School of Nursing and Public Health, South Africa and the University of Technology Sydney, Australia.  My work is primarily in South Africa and includes epidemiologic, interventional and implementation science research as well as capacity development initiatives with a specific focus on the intersection of HIV/AIDS and associated co-morbidities, particularly in the realm of co-infections harboring antimicrobial resistance.  My primary interests are: 

(1) Patient-Centered Outcomes Research. Through an NIAID/NIH funded R01, I am conducting a cluster randomized trial of nurse case management as an intervention to improve MDR-TB treatment outcomes among HIV co-infected patients.  My team, in collaboration with the Medical Research Council, also published a large cohort study of MDR-TB outcomes by HIV status prior to ART access from South Africa called the DOTS Plus Study. 

(2) Expanded Access to Care Models and Implementation Science. I am currently the PI on a Centers for Disease Control and Prevention supported MDR-TB project and the primary MDR-TB sub-recipient of a Global Fund for AIDS, TB and Malaria grant in collaboration with the South African National Department of Health Drug Resistant TB Directorate and JHPIEGO-South Africa.  Each of these efforts encompasses programmatic and implementation science initiatives that include the whole of South Africa with a team of over 50 individuals.  Through these programs we are expanding access to community-based care models where nurse are the primary treating clinician.  In this role, I serve on a strategic planning committee (think tank) for the South Africa National Department of Health Drug Resistant TB Directorate. 

(3) TB Infection Prevention and Control (IPC).  My work in TB-IPC includes the assessment and evaluation of MDR-TB hospitals throughout South Africa with regard to the human factors of TB-IPC.  My team has focused on the protection of both healthcare workers and patients in these settings.  I also strongly believe that these protections should be implemented across the care continuum and in both clinical and research settings. 

(4) Capacity Development and Mentoring.  Teaching and mentoring of pre-service and in-service healthcare workers is exceptionally important.  To do this on a greater scale than I could ever do in person, I co-teach with Dr. Chaisson a Coursera open course of TB Clinical Management and Research.  To date, participants from 126 countries have participated in this course.   Outside of this course, my team offers a one week didactic inter-professional training to nurses, physicians and other healthcare workers in MDR-TB Management in South Africa.  This includes capacitating primary healthcare nurses (nurse practitioner) to diagnose, treat and manage MDR-TB patients.  Finally, I see the mentorship of doctoral students and post-docs as a key priority to grow the next generation of scientist in TB. 

Categories

Events

«

November 2017

»
S
M
T
W
T
F
S
·
·
·
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
·
·

Projects

TB Modeling and Analysis Consortium

The TB MAC brings TB modelers together from a wide range of institutions to answer questions of global policy relevance.  I...

Read More

Impact of diabetes on TB treatment outcomes...

This is a study to prospectively enroll and follow TB patients co-infected with diabetes and TB patients without diabetes...

Read More

Modeling the impact of spatially targeted TB...

We have developed transmission models to understand the impact of TB vaccination strategies that target hotspots of...

Read More